Codiak BioSciences, Inc. Conversion of Stock, Amount Converted
Codiak BioSciences, Inc. reported Conversion of Stock, Amount Converted of $225.57 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2022-03-10
- Codiak BioSciences, Inc. conversion of stock, amount converted for fiscal 2020 was $225.57M.
| Period end | Conversion of Stock, Amount Converted 12 month |
|---|---|
| 2020-12-31 | $225.57M 10-K · filed 2022-03-10 |